AMAL THERAPEUTICS
Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Amal Therapeutics was incorporated in September 2012. Amal uses its proprietary cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology.
AMAL THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Neuroscience Therapeutics
Founded:
2012-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.amaltherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
45.34 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Microsoft Azure DNS Facebook Sharer Facebook Domain Verification GlobalSign Domain Verification Incapsula Nameshield
Current Advisors List
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Amal Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - Amal Therapeutics
BioMedPartners
BioMedPartners investment in Series B - Amal Therapeutics
Schroder Adveq
Schroder Adveq investment in Series B - Amal Therapeutics
3B Future Health Fund
3B Future Health Fund investment in Series B - Amal Therapeutics
VI Partners
VI Partners investment in Series B - Amal Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - Amal Therapeutics
Schroder Adveq
Schroder Adveq investment in Series B - Amal Therapeutics
BioMedPartners
BioMedPartners investment in Series B - Amal Therapeutics
3B Future Health Fund
3B Future Health Fund investment in Series B - Amal Therapeutics
Official Site Inspections
http://www.amaltherapeutics.com
- Host name: 45.60.65.30
- IP address: 45.60.65.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amal Therapeutics"
amaltherapeutics.com - Transforming the prospects of cancer …
Oct 20, 2022 Harnessing the power of KISIMA® immunisation technology to discover and develop therapeutic vaccinesSee details»
Leadership Team - Amal Therapeutics - amaltherapeutics.com
AMAL Therapeutics is led by a dedicated team with a strong background in molecular and cellular biotechnology R&D gained from working within start-ups, at renowned Academic Institutes, as …See details»
Amal Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Amal …See details»
BI Acquires AMAL Therapeutics | Boehringer Ingelheim US
Tel: +44 (0) 207 457 2020 [email protected]. Media Contacts. Linda Ruckel 900 Ridgebury Rd. P.O. Box 368 Ridgefield, CT 06877. Phone +1 (203) 791-6672. …See details»
Amal Therapeutics SA – Swiss Biotech
[email protected]; Location. Avenue de la Roseraie 64, 1205 Genève, Switzerland. Get Directions Canton. Geneva; Facts & figures. Type of organization. Private company. Year …See details»
Amal Therapeutics Company Profile 2024: Valuation, …
Amal Therapeutics General Information Description. Developer of therapeutic vaccines designed to facilitate oncology treatment. The company's peptide-based vaccines generate a cellular immune response including activation of killer T …See details»
Amal Therapeutics - LIVE
AMAL Therapeutics (AMAL) is a biotech, developing unique therapeutic vaccines and a distinct unit of the Discovery Research organization of the Boehringer Ingelheim group of companies. …See details»
Amal Therapeutics - VentureRadar
"AMAL Therapeutics (AMAL) is a pre-clinical stage Swiss biotech, developing unique therapeutic vaccines. Our aim is to overcome the challenges around effective anti-cancer therapy by …See details»
Amal Therapeutics SA - Genf, Switzerland - bionity.com
Amaltherapeutics.com. Contact. Profile Products News. Contact. About Amal Therapeutics. Amal Therapeutics SA is a privately held Swiss biotech start-up company and a spin-off from the …See details»
AMAL Therapeutics - Overview, News & Similar companies
Jul 15, 2019 AMAL Therapeutics contact info: Phone number: +41 223794688 Website: www.amaltherapeutics.com What does AMAL Therapeutics do? AMAL Therapeutics SA is a …See details»
Amal Therapeutics Company Overview, Contact Details
[email protected]: 45%. See more formats. Frequently Asked Questions Where is Amal Therapeutics 's headquarters located? Amal Therapeutics 's main headquarters is …See details»
Amal Therapeutics - Craft
Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology. The Company uses its cell penetrating peptide platform to …See details»
AMAL Therapeutics - Association GEnevoise pour les Métiers de …
Technology Platform. AMAL Therapeutics developed a versatile and flexible recombinant protein vaccine technology platform called KISIMA Ò.KISIMA is a three-component chimeric protein …See details»
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly ...
Jul 15, 2019 Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform. Ingelheim am Rhein, …See details»
☑️Amal Therapeutics — Consulting Organization from …
Dec 6, 2024 Amal Therapeutics — Consulting Organization from Switzerland, has experience with European Commission Directorate-General for International Partnerships (EuropeAid …See details»
Amal Therapeutics SA - Venturelab
Mar 9, 2012 Amal Therapeutics SA : Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.See details»
Amal Therapeutics SA - startup.ch
Amal Therapeutics SA : Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.See details»
AMAL Therapeutics to publish research outcomes in Cancers
AMAL Therapeutics to publish research outcomes in Cancers. Geneva, Switzerland, October 20, 2022 – AMAL Therapeutics announced today that the latest findings of its research team is on …See details»
News - amaltherapeutics.com
Geneva, Switzerland, August 31, 2021 - AMAL Therapeutics announced today that the latest findings of its in vivo research team, in collaboration with Prof. Guido Wollman’s lab at the …See details»